A protein-targeting strategy used to develop a selective inhibitor of the E17K point mutation in the PH domain of Akt1.Published in:Nature Chemistry, 2015, v. 7, n. 5, p. 455, doi. 10.1038/nchem.2223By:Deyle, Kaycie M.;Farrow, Blake;Qiao Hee, Ying;Work, Jeremy;Wong, Michelle;Lai, Bert;Umeda, Aiko;Millward, Steven W.;Nag, Arundhati;Das, Samir;Heath, James R.Publication type:Article